213 related articles for article (PubMed ID: 22109577)
1. [Acute lymphoblastic leukemia in the adult].
Gökbuget N
Dtsch Med Wochenschr; 2011 Dec; 136(48):2466-9. PubMed ID: 22109577
[No Abstract] [Full Text] [Related]
2. [Therapy of adult acute lymphoblastic leukemia].
Bernasconi C
Haematologica; 1991 Jun; 76 Suppl 3():58-64. PubMed ID: 1752544
[No Abstract] [Full Text] [Related]
3. Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia.
Foroni L; Hoffbrand AV
Best Pract Res Clin Haematol; 2002 Mar; 15(1):71-90. PubMed ID: 11987917
[TBL] [Abstract][Full Text] [Related]
4. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
[TBL] [Abstract][Full Text] [Related]
6. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
Foroni L; Harrison CJ; Hoffbrand AV; Potter MN
Br J Haematol; 1999 Apr; 105(1):7-24. PubMed ID: 10366253
[No Abstract] [Full Text] [Related]
7. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia.
Fuster JL; Bermúdez M; Galera A; Llinares ME; Calle D; Ortuño FJ
Haematologica; 2007 Dec; 92(12):1723-4. PubMed ID: 18056006
[TBL] [Abstract][Full Text] [Related]
9. Eliminating a gold standard in childhood acute lymphoblastic leukemia?
Raetz EA; Carroll WL
Pediatr Blood Cancer; 2006 Sep; 47(3):242-4. PubMed ID: 16421903
[No Abstract] [Full Text] [Related]
10. [Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy].
Hoelzer D; Gökbuget N; Arnold R; Büchner T; Freund M; Gassmann W; Heil G; Hiddemann W; Löffler H; Lipp T; Ludwig WD; Maschmeyer G; Thiel E; Messerer D
Internist (Berl); 1996 Oct; 37(10):994-1007. PubMed ID: 9019457
[No Abstract] [Full Text] [Related]
11. [Acute lymphoblastic leukemia and chronic lymphocytic leukemia in adults].
Usui N
Rinsho Ketsueki; 2012 Feb; 53(2):164-75. PubMed ID: 22450575
[No Abstract] [Full Text] [Related]
12. [Acute lymphoblastic leukemia].
Kowata S; Ishida Y
Nihon Rinsho; 2001 Nov; 59 Suppl 7():521-7. PubMed ID: 11808162
[No Abstract] [Full Text] [Related]
13. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
Takeuchi J
Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
[No Abstract] [Full Text] [Related]
14. Adult acute leukemia.
Hoelzer D; Büchner T; Gale RP; Zittoun R
Rev Invest Clin; 1994 Apr; Suppl():21-5. PubMed ID: 7886303
[No Abstract] [Full Text] [Related]
15. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shin HJ; Chung JS; Cho GJ
Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
[No Abstract] [Full Text] [Related]
16. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
Herold R; von Stackelberg A; Hartmann R; Eisenreich B; Henze G
J Clin Oncol; 2004 Feb; 22(3):569-70; author reply 570-1. PubMed ID: 14752084
[No Abstract] [Full Text] [Related]
17. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
de Bont JM; Holt Bv; Dekker AW; van der Does-van den Berg A; Sonneveld P; Pieters R
Leukemia; 2004 Dec; 18(12):2032-5. PubMed ID: 15483674
[No Abstract] [Full Text] [Related]
18. Acute leukemia in adolescents and young adults.
Advani AS; Hunger SP; Burnett AK
Semin Oncol; 2009 Jun; 36(3):213-26. PubMed ID: 19460579
[TBL] [Abstract][Full Text] [Related]
19. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
Carella AM
Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
[No Abstract] [Full Text] [Related]
20. Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols.
Meleshko AN; Savva NN; Fedasenka UU; Romancova AS; Krasko OV; Eckert C; von Stackelberg A; Aleinikova OV
Leuk Res; 2011 Oct; 35(10):1312-20. PubMed ID: 21596436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]